Electrophilic C12 building blocks for alkaloids: 1,1 iterative organoiron-mediated routes to (±)-lycoramine and (±)-maritidine

European Journal of Organic Chemistry

Volumn , Issue 9, 2011, Pages 1664-1681

  Stephenson, G Richard ^a   Roe, Caroline ^a   Sandoe, Elizabeth J ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Alkaloids; Asymmetric synthesis; Cations; Iron complexes; Lycoramine; Maritidine; Regioselectivity

Indexed keywords

EID: 79952497162     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.201001394     Document Type: Article

References (163)

1. For examples of applications of organoiron complexes, see
2. H.-J. Knölker, Iron Diene Complexes, Transition Metals for Organic Synthesis, vol. 2 (Eds.:, M. Beller, C. Bolm), Wiley-VCH, Weinheim, Germany, 2004, 1, pp. 585-599.
3. G. R. Stephenson, in: Organometallic Complexes of Iron, in: Science of Synthesis, Houben-Weyl, Methods of Molecular Transformations, vol. 1 (Ed.:, M. Lautens), Thieme, Stuttgart, Germany, 2001, pp. 745-886.
4. H.-J. Knölker, A. Braier, D. J. Brocher, S. Cammerer, W. Frohner, P. Gonser, H. Hermann, D. Hertzberg, K. R. Reddy, G. Rhode, Pure Appl. Chem. 2001, 73, 1075-1086.
5. H.-J. Knölker, Chem. Soc. Rev. 1999, 28, 151-157.
6. W. A. Donaldson, Curr. Org. Chem. 2000, 4, 837-868.
7. 5 Complexes in Organic Synthesis, Organic Synthesis Highlights, 2 (Ed.:, H. Waldmann), VCH, Weinheim, Germany, 1995, pp. 59-64. planar chirality of organoiron complexes as a control strategy
8. I. M. Palotai, G. R. Stephenson, L. A. P. Kane-Maguire, J. Organomet. Chem. 1987, 319, C5-C10. for absolute configurations, see
9. P. W. Howard, G. R. Stephenson, S. C. Taylor, J. Chem. Commun. 1991, 127-129.
10. G. R. Stephenson, Aust. J. Chem. 1981, 34, 2339-2345.
11. A. J. Birch, W. D. Raverty, G. R. Stephenson, J. Chem. Soc., Chem. Commun. 1980, 857-859. for earlier reviews of the applications of the cyclohexadienyliron series, see
12. A. J. Pearson, Acc. Chem. Res. 1980, 13, 463-469.
13. A. J. Pearson, Synlett 1990, 10-19.
14. H.-J. Knölker, Synlett 1992, 371-387.
15. W. A. Donaldson, Aldrichimica Acta 1997, 30, 17-24.
16. R. Grée, Synthesis 1989, 341-355.
17. G. R. Stephenson, in: Handbook of Functionalised, Organometallics (Ed.:, P. Knochel), Wiley-VCH, Weinheim, Germany, 2005, pp. 569-626; examples:.
18. A. J. Pearson, P. Ham, J. Chem. Soc., Perkin Trans. 1 1983, 1421-1425 (applied to hitrionicotoxin)
19. A. J. Birch, A. J. Liepa, G. R. Stephenson, J. Chem. Soc. Perkin Trans. 1 1982, 713-717 (applied to ellipticine)
20. A. J. Pearson, D. C. Rees, J. Chem. Soc. Perkin Trans. 1 1982, 2467-2776 (applied to limaspermine)
21. [61].
22. D. A. Owen, A. V. Malkov, I. M. Palotai, C. Roe, E. J. Sandoe, G. R. Stephenson, Chem. Eur. J. 2007, 13, 4293-4311.
23. G. R. Stephenson, R. P. Alexander, C. Morley, P. W. Howard, Phil. Trans. R. Soc. Lond. A 1988, 326, 545-556.
24. C. E. Anson, A. V. Malkov, C. Roe, E. J. Sandoe, G. R. Stephenson, Eur. J. Org. Chem. 2008, 196-213.
25. [50]), and subsequently reviewed: Advanced Asymmetric Synthesis (Ed.:, G. R. Stephenson), Blackie, London, 1996, chapter 16, pp. 315-317.
26. 5-cyclohexadienyl)iron series of electrophiles:, G. R. Stephenson, S. T. Astley, I. M. Palotai, P. W. Howard, D. A. Owen, S. Williams, in: Organic Synthesis via Organometallics (Eds.:, K. H. Dötz, R. W. Hoffmann), Vieweg, Braunschweig, Germany, 1991, pp. 169-185.
27. G. R. Stephenson, A. M. Balfe, D. L. Hughes, R. D. Kelsey, Tetrahedron Lett. 2010, in press.
28. C. E. Anson, S. Hartmann, R. D. Kelsey, G. R. Stephenson, Polyhedron 2000, 19, 569-571.
29. S. T. Astley, M. Meyer, G. R. Stephenson, Tetrahedron Lett. 1993, 34, 2035-2038.
30. S. T. Astley, G. R. Stephenson, J. Chem. Soc. Perkin Trans. 1 1992, 1953-1955.
31. S. T. Astley, G. R. Stephenson, Synlett 1992, 507-509.
32. G. R. Stephenson, I. M. Palotai, W. J. Ross, D. E. Tupper, Synlett 1991, 586-588.
33. This issue was first discussed in the context of synthetic routes to tridachiapyrones
34. R. P. Alexander, C. Morley, G. R. Stephenson, J. Chem. Soc. Perkin Trans. 1 1988, 2069-2074. for work on related target molecules, see
35. R. P. Alexander, T. D. James, G. R. Stephenson, J. Chem. Soc., Dalton Trans. 1987, 299, 2013-2016.
36. R. P. Alexander, G. R. Stephenson, J. Organomet. Chem. 1986, 314, C73-C75.
37. R. P. Alexander, G. R. Stephenson, J. Organomet. Chem. 1986, 299, C1-C3.
38. G. R. Stephenson, J. Chem. Soc. Perkin Trans. 1 1982, 2449-2456.
39. [4]
40. E. J. Sandoe, G. R. Stephenson, S. Swanson, Tetrahedron Lett. 1996, 37, 6283-6286.
41. C. Roe, G. R. Stephenson, Org. Lett. 2008, 10, 189-192.
42. H. Kondo, K. Tomimura, S. Ishiwata, J. Pharm. Soc. Jpn. 1932, 52, 433-458.
43. H. Kondo, S. Ishiwata, Ber. Dtsch. Chem. Ges. 1937, 70, 2427-2437.
44. S. Uyeo, S. Kobayashi, Pharm. Bul. 1953, 1, 139-142.
45. Z. Jin, Nat. Prod. Rep. 2009, 26, 363-381.
46. Z. Jin, Nat. Prod. Rep. 2007, 24, 886-905.
47. S. Prabhakar, M. R. Tavares, Alkaloids: Chemical and Biological Perspectives 2001, 15, 433-572.
48. The Amaryllidaceae alkaloids are still a rich source of new potentially biologically active target structures with substantial synthetic challenges:, N. Unver, Phytochem. Rev. 2007, 6, 125-135.
49. O. Hoshino, The Amaryllidaceae alkaloids, Alkaloids, Academic Press, 1998, 51, chapter 4, pp. 324-424.
50. S. F. Martin, in: The Alkaloids (Ed.:, A. Brossi), Academic Press, New York, 1987, 30, pp. 251-376.
51. S. Y. Han, J. E. Sweeney, E. S. Bachman, E. J. Schweiger, G. Forloni, J. T. Coyle, B. M. Davis, M. M. Joullie, Eur. J. Med. Chem. 1992, 27, 673-687.
52. K.-C. Chao, C.-L. Chao, C.-C. Hu, Yaoxue Xuebao 1965, 12, 36-44.
53. R. L. Irwin, H. J. Smith III, Biochem. Pharmacol. 1960, 3, 147-148.
54. S. Lopez, J. Bastida, F. Viladomat, C. Codina, Life Sci. 2002, 71, 2521-2529.
55. B. M. Davis, PCT Int. Appl. WO 2000030446, 2000.
56. S. C. Quay, U. S. Pat. Appl. US 2003225031, 2003.
57. A. Maclicke, PCT Int. Appl. WO 200739138, 2007.
58. C. Bartolucci, E. Perola, C. Pilger, G. Fels, D. Lamba, Proteins Struct., Funct., Bioinf. 2001, 42, 182-191.
59. Analogues of galanthamine and lycoramine have activity as modulators of nicotinic receptors, see
60. B. Davis, US patent US 148253, 2002.
61. B. Davis, PCT Int. Appl. WO 2001043697, 2001.
62. K. Hostettmann, A. Marston, Chimia 2007, 61, 322-326.
63. M. Heinrich, H. L. Teoh, J. Ethnopharmacol. 2004, 92, 147-162.
64. R. Bullock, Expert Rev. Neurother. 2004, 4, 153-163.
65. J. Corey-Bloom, Int. J. Clin. Pract. 2003, 57, 219-223.
66. D. G. Wilkinson, Expert Rev. Neurother. 2001, 1, 153-159. for galanthamine in the treatment of Alzheimer's disease, see
67. M. Weinstock, CNS Drugs 1999, 11, 307-323.
68. K. Unni, CNS Drugs 1998, 10, 447-460.
69. E. Giacobini, Neurochem. Int. 1998, 32, 413-419.
70. H. A. M. Mucke, Drugs Today 1997, 33, 251-257.
71. H. A. M. Mucke, Drugs Today 1997, 33, 259-264.
72. Disorders of attention (e.g. attention deficit disorder or Tourette's syndrome) have been treated by administering lycoramine, O-desmethyllycoramine, or an ester, ether, carbamate or carbonate derivative, see:, B. M. Davis, PCT Int. Appl. WO 9921561, 1999.
73. J. E. Somers, R. L. Irwin, G. M. Shy, Neurology 1963, 13, 543-553.
74. Kh. U. Aliev, in Farmakol. Rastit. Veshchestv (Ed.:, M. B. Sultanov), 1976, pp. 116-125.
75. R. L. Irwin, H. J. Smith III, M. M. Hein, J. Pharmacol. Exp. Ther. 1961, 134, 53-59.
76. R. V. K. Rao, J. V. L. N. S. Rao, Curr. Sci. 1979, 48, 110-111.
77. M. R. Herrera, A. K. Machocho, R. Brun, F. Viladomat, C. Codina, J. Bastida, Planta Med. 2001, 67, 191-193.
78. M. Alarcon, G. Cea, G. Weigert, Environ. Contam. Toxicol. 1986, BI, 508-512.
79. G. Cea, M. Alarcon, G. Weigart, Med. Sci. 1986, 14, 90.
80. E. E. Elgorashi, G. I. Stafford, A. K. Jager, J. Van Staden, Planta Med. 2006, 72, 470-473.
81. For earlier syntheses, see
82. N. Hazama, H. Irie, T. Mizutani, T. Shingu, M. Takada, S. Uyeo, A. Yoshitake, J. Chem. Soc., C 1968, 2947-2953.
83. Y. Misaka, T. Mizutani, M. Sekido, S. Uyeo, J. Chem. Soc. C 1968, 2954-2949.
84. for a review of the total synthesis of lycoramine published since 1967, see: Synform 1983, 4, 295-305.
85. For examples of synthetic routes to galanthamine, see
86. V. Satcharoen, N. J. McLean, S. C. Kemp, N. P. Kamp, R. C. D. Brown, Org. Lett. 2007, 9, 1867-1869.
87. X.-D. Hu, Y. Q. Tu, E. Zhang, S. Gao, S. Wang, A. Wang, C. Fan, M. Wang, Org. Lett. 2006, 8, 1823-1825.
88. M. Node, S. Kodama, Y. Hamashima, T. Katoh, K. Nishude, T. Kajemoto, Chem. Phar. Bull. 2006, 54, 1662-1679.
89. B. M. Trost, W. Tang, F. D. Toste, J. Am. Chem. Soc. 2005, 127, 14785-14803.
90. for the conversion of lycoramine into galanthamine, see:, T. Liu, X.-Z. Chen, R.-B. Du, G.-H. Xu, Y. An, Huaxue Xuebao 2007, 65, 711-714.
91. S. F. Martin, P. J. Garrison, J. Org. Chem. 1982, 47, 1513-1518.
92. C.-A. Fan, Y.-Q. Tu, Z.-L. Song, E. Zhang, L. Shi, M. Wang, B. Wang, S.-Y. Zhang, Org. Lett. 2004, 6, 4691-4694.
93. E. Gras, C. Guillou, C. Thal, Tetrahedron Lett. 1999, 40, 9243-9244.
94. M. Essamkaoui, A. Benharref, H. Moskowitz, J. Mayrargue, C. Thal, Heterocycl. Commun. 1996, 4, 319-323.
95. W. P. Malachowski, T. Paul, S. Phounsavath, J. Org. Chem. 2007, 72, 6792-6796.
96. P.-H. Liang, J.-P. Liu, L.-W. Hsin, C.-Y. Cheng, Tetrahedron 2004, 60, 11655-11660.
97. M. Ishizaki, K. Ozaki, A. Kanematsu, I. Akira, O. Hoshino, J. Org. Chem. 1993, 58, 3877-3885.
98. K. A. Parker, H. J. Kim, J. Org. Chem. 1992, 57, 752-755.
99. A. G. Schultz, Y. K. Yee, M. H. Berger, J. Am. Chem. Soc. 1977, 99, 8065-8067.
100. a photochemical approach has also been used to make lycoramine analogues, see:, A. Missoum, M.-E. Sinibaldi, D. Vallee-Goyet, J.-C. Gramain, Synth. Commun. 1997, 27, 453-466.
101. I. H. Sanchez, J. J. Soria, F. J. Lopez, M. I. Larraza, H. J. Flores, J. Org. Chem. 1984, 49, 157-163.
102. [66]). This is the formal umpolung of our cyclohexadienyliron method.
103. M. A. Schwartz, R. A. Holton, J. Am. Chem. Soc. 1970, 92, 1090-1092.
104. S. Yamada, K. Tomioka, K. Koga, Tetrahedron Lett. 1976, 17, 57-60.
105. E. Kotani, N. Takeuchi, S. Tobinaga, Tetrahedron Lett. 1973, 14, 2735-2736.
106. E. Kotani, N. Takeuchi, S. Tobinaga, J. Chem. Soc., Chem. Commun. 1973, 550-551.
107. T. Kametani, T. Kohno, S. Shibuya, K. Fukumoto, Tetrahedron 1971, 27, 5441-5444.
108. Y. Kita, T. Takada, M. Gyoten, H. Tohma, M. H. Zenk, J. Eichhorn, J. Org. Chem. 1996, 61, 5857-5864.
109. Y. Kita, M. Arisawa, M. Gyoten, M. Nakajima, R. Hamada, H. Tohma, T. Takada, J. Org. Chem. 1998, 63, 6625-6633.
110. S. V. Ley, O. Schucht, A. W. Thomas, P. J. Murray, J. Chem. Soc., Perkin Trans. 1 1999, 1251-1252.
111. C. Bru, C. Thal, C. Guillou, Org. Lett. 2003, 5, 1845-1846.
112. A. J. Birch, P. E. Cross, J. Lewis, D. A. White, S. B. Wild, J. Chem. Soc. A 1968, 332-340.
113. G. R. Stephenson, H. Finch, D. A. Owen, S. Swanson, Tetrahedron 1993, 49, 5649-5662.
114. D. Magdziak, L. H. Pettus, T. R. R. Pettus, Org. Lett. 2001, 3, 557-559.
115. J. E. J. Older, PhD Thesis, University of East Anglia, 2001.
116. J. E. J. Older, G. R. Stephenson, unpublished results.
117. A. V. Malkov, A. Auffrant, C. Renard, E. Rose, F. Rose-Munch, D. A. Owen, E. J. Sandoe, G. R. Stephenson, Inorg. Chim. Acta 1999, 296, 139-149.
118. C. Roe, E. J. Sandoe, G. R. Stephenson, C. E. Anson, Tetrahedron Lett. 2008, 49, 650-653.
119. C. J. Bungard, J. C. Morris, Synthesis 2001, 741-744.
120. P. J. Kocienski, Protecting Groups, 3rd ed., Thieme, Stuttgart, Germany, 1994, pp. 72-74.
121. for example, see:, A. F. Kluge, K. G. Untch, J. H. Fried, J. Am. Chem. Soc. 1972, 94, 7827-7832.
122. B. H. Lipshutz, J. J. Pegram, Tetrahedron Lett. 1980, 21, 3343-3346. see also:, B. E. Blass, C. L. Harris, D. E. Portlock, Tetrahedron Lett. 2001, 42, 1611 -1613.
123. For example, see
124. H. Togo, O. Kikuchi, Heterocycles 1989, 28, 373-381, but for 4d, THF was used in place of DMF
125. see also:, S. Krompiec, N. Kuznik, R. Penczek, J. Rzepa, J. Mrowiec-Bialon, J. Mol. Catal. A 2004, 219, 29-40.
126. B. M. R. Bandara, A. J. Birch, T.-C. Khor, Tetrahedron Lett. 1980, 21, 3625-3626.
127. 2 group. The β hydrogen at C-6 was not affected: D. A. Owen, PhD Thesis, University of East Anglia, Norwich, 1990, p. 85.
128. The corresponding aryllithium reagent has been studied in detail, see
129. H. J. Reich, W. H. Sikorski, B. O. Gudmundsson, R. R. Dykstra, J. Am. Chem. Soc. 1998, 120, 4035-4036. see also
130. C. A. Townsend, L. M. Bloom, Tetrahedron Lett. 1981, 22, 3923-3924. for example of applications, see
131. C. Li, A. C. Heimann, S. J. Danishefsky, Angew. Chem. 2007, 119, 1466;
132. Angew. Chem. Int. Ed. 2007, 46, 1444-1447.
133. D. Y. W. Lee, W.-Y. Zhang, V. V. R. Karnati, Tetrahedron Lett. 2003, 44, 6857-6859.
134. S.-S. Jew, H.-A. Kim, S.-Y. Bae, J.-H. Kim, H.-G. Park, Tetrahedron Lett. 2000, 41, 7925-7928.
135. D. A. Owen, G. R. Stephenson, H. Finch, S. Swanson, Tetrahedron Lett. 1990, 31, 3401-3404.
136. P. W. Howard, G. R. Stephenson, S. C. Taylor, J. Chem. Soc., Chem. Commun. 1990, 1182-1184.
137. P. W. Howard, G. R. Stephenson, S. C. Taylor, J. Organomet. Chem. 1989, 370, 97-109.
138. 5 cations, see
139. R. P. Alexander, G. R. Stephenson, J. Chem. Soc., Dalton Trans. 1987, 885-888.
140. W. D. Meng, G. R. Stephenson, J. Organomet. Chem. 1989, 371, 355-360.
141. [2].
142. [2]
143. Y. Shvo, E. Hazum, J. Chem. Soc., Chem. Commun. 1974, 336-337. for examples in organoiron-mediated synthesis, see
144. A. J. Pearson, P. Ham, C. W. Ong, T. R. Perrior, D. C. Rees, J. Chem. Soc. Perkin Trans. 1 1982, 1527-1534.
145. B. M. R. Bandara, A. J. Birch, L. F. Kelly, J. Org. Chem. 1989, 49, 4663-4763.
146. A. J. Birch, L. F. Kelly, D. V. Weerasuria, J. Org. Chem. 1988, 53, 278-281.
147. [50].
148. D. J. Ackland, J. T. Pinhey, J. Chem. Soc. Perkin Trans. 1 1987, 12, 2695-2700.
149. For recent examples of the use of the Pictet-Spengler reaction in alkaloid synthesis, see
150. T. Godecke, D. C. Lankin, D. Nikolic, S.-N. Chen, R. B. van Breemen, N. R. Farnsworth, G. F. Pauli, Org. Lett. 2009, 11, 1143-1146.
151. P. K. Agarwal, S. K. Sharma, D. Sawant, B. Kundu, Tetrahedron 2009, 65, 1153-1161.
152. Y.-C. Wu, M. Liron, J. Zhu, J. Am. Chem. Soc. 2008, 130, 7148-7152. For an example employing organoiron complexes, see
153. A. J. Pearson, P. Ham, C. W. Ong, T. R. Perrior, D. C. Rees, J. Chem. Soc. Perkin Trans. 1 1982, 1527-1534.
154. L. Crombie, J. L. Josephs, J. Chem. Soc. Perkin Trans. 1 1993, 2599-2604.
155. T. W. Greene, P. G. M. Wuts, Protective Groups in Organic Synthesis, John Wiley & Sons, 1999.
156. M. Chandler, P. J. Parsons, E. Mincione, Tetrahedron Lett. 1983, 24, 5781-5784.
157. M. I. Naumov, S. A. Sutirin, A. S. Shavyrin, O. G. Ganina, I. P. Beletskaya, V. Bourgarel-Rey, S. F. Combes, J.-P. Finet, A. Y. Fedorov, J. Org. Chem. 2007, 72, 3293-3301.
158. T. Hasegawa, H. Yamamoto, Synthesis 2003, 1181-1186.
159. E. N. Tsvetkov, V. Kh. Syundyukova, V. E. Baulin, Izv. Akad. Nauk SSSR, Ser. Khim. 1989, 147-150.
160. S. P. Khanapure, E. R. Biehl, J. Org. Chem. 1990, 55, 1471-1475.
161. M. I. Naumov, S. A. Sutirin, A. S. Shavyrin, O. G. Ganina, I. P. Beletskaya, V. Bourgarel-Rey, S. Combes, J. P. Finet, A. U. Federov, J. Org. Chem. 2007, 72, 3293-3301.
162. L. Crombie, J. L. Josephs, J. Chem. Soc. Perkin Trans. 1 1993, 2599-2604.
163. S. V. Ley, O. Schucht, A. W. Thomas, P. J. Murray, J. Chem. Soc., Perkin Trans. 1 1999, 1251-1252.